Form 4 for PODD Insulet Corporation
Accepted 2023-01-06 00:00:00 ET · period of report 2023-01-04 · accession 0001127602-23-001064 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-01-06 | 2023-01-04 | PODD | Petrovic Shacey | Dir | M - OptEx | $54.81 | +15.0K | 25.2K | +147% | +$822.1K |
| D | 2023-01-06 | 2023-01-04 | PODD | Petrovic Shacey | Dir | S - Sale+OE | $281.88 | -15.0K | 14.8K | -50% | -$4.23M |
| DM | 2023-01-06 | 2023-01-04 | PODD | Petrovic Shacey | Dir | M - OptEx | $0.00 | -15.0K | 11.8K | -56% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-04 | M | A | 4,555 | $74.50 | 29,789 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. |
| 2 | Common | Common Stock | 2023-01-04 | S | D | 15,000 | $281.88 | 14,789 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. (F3) Footnote continued:898 shares were sold in the range of $282.73 to $283.68, with a weighted average share price of $283.33; 1,184 shares were sold in the range of $283.78 to $284.53, with a weighted average share price of $284.06; 700 shares were sold in the range of $284.82 to $285.18, with a weighted average share price of $284.89; 800 shares were sold in the range of $286.44 to $286.79, with a weighted average share price of $286.66; 300 shares were sold in the range of $287.68 to $288.45, with a weighted average share price of $288.10; 306 shares were sold in the range of $289.25 to $289.70, with a weighted average share price of $289.38. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. (F2) The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $278.63 to $289.70. Specifically: 3,144 shares were sold in the range of $278.63 to $279.62, with a weighted average share price of $279.20; 2,556 shares were sold in the range of $279.65 to $280.59, with a weighted average share price of $280.05; 2,337 shares were sold in the range of $280.66 to $281.39, with a weighted average share price of $281.13; 2,775 shares were sold in the range of $281.67 to $282.55, with a weighted average share price of $282.17; |
| 3 | Common | Common Stock | 2023-01-04 | M | A | 10,445 | $46.22 | 25,234 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. |
| 4 | Derivative | Employee Stock Option (Right to Buy) | 2023-01-04 | M | D | 10,445 | $0.00 | 0 | D | $46.22 · — to 2027-02-22 | 10,445 Common Stock | (F4) This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2023-01-04 | M | D | 4,555 | $0.00 | 11,838 | D | $74.50 · — to 2028-02-14 | 4,555 Common Stock | (F4) This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. |